Potential Impact (Benefit) of Preventative Treatment With Topamax on the Effectiveness of Axert in the Acute Treatment of Migraine
PHASE4CompletedINTERVENTIONAL
Enrollment
406
Participants
Timeline
Start Date
June 30, 2005
Study Completion Date
June 30, 2007
Conditions
MigraineClassic MigraineCommon Migraine
Interventions
DRUG
topiramate; almotriptan malate
All Listed Sponsors
collaborator
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
INDUSTRY
lead
Janssen-Ortho LLC
INDUSTRY
NCT00210496 - Potential Impact (Benefit) of Preventative Treatment With Topamax on the Effectiveness of Axert in the Acute Treatment of Migraine | Biotech Hunter | Biotech Hunter